Evidence map›Paper›PMID 23625540›Full record

ArticleCancer2013

Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention.

Jeanne Mandelblatt, Nicolien van Ravesteyn, Clyde Schechter, Yaojen Chang, An-Tsun Huang, Aimee M Near, Harry de Koning, Ahmedin Jemal

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Systematic Review of the Cost Effectiveness of Breast Cancer Prevention, Screening, and Treatment Interventions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2020
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators.Medical decision making : an international journal of the Society for Medical Decision Making · 2019
    Article
  7. Article
  8. Contribution of Breast Cancer to Overall Mortality for US Women.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  9. Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  10. Simulating the Impact of Risk-Based Screening and Treatment on Breast Cancer Outcomes with MISCAN-Fadia.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  11. Structure, Function, and Applications of the Georgetown-Einstein (GE) Breast Cancer Simulation Model.Medical decision making : an international journal of the Society for Medical Decision Making · 2018
    Article
  12. Article
  13. Article
  14. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jeanne MandelblattDepartment of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, DC, USA. mandelbj@georgetown.edu
Nicolien van Ravesteyn
Clyde Schechter
Yaojen Chang
An-Tsun Huang
Aimee M Near
Harry de Koning
Ahmedin Jemal
Georgetown University · USErasmus MC · NLAlbert Einstein College of Medicine · USAmerican Cancer Society · US

Funding

Risk-based Imaging Strategies to Improve Breast Cancer Surveillance OutcomesP01CA154292 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KARLA M KERLIKOWSKE, Diana L Miglioretti · 2011 to 2026
$52.9M
Statistical Coordinating Center for the Breast Cancer Surveillance ConsortiumU01CA086076 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI MIGLIORETTI, DIANA L · 2000 to 2011
$8.5M
Comparative Modeling: Informing Breast Cancer Control Practice & PolicyU01CA152958 · NCI · GEORGETOWN UNIVERSITY · PI BERRY, DONALD A, DE KONING, HARRY J · 2010 to 2015
$7.6M
IMPROVING THE QUALITY OF MAMMOGRAPHIC INTERPRETATIONU01CA063731 · NCI · KAISER FOUNDATION HEALTH PLAN OF WASHINGTON · PI BUIST, DIANA SM · 1994 to 2011
$6.7M
VERMONT BREAST CANCER SURVEILLANCE SYSTEMU01CA070013 · NCI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GELLER, BERTA M · 1995 to 2011
$6.7M
UTILITY AND OUTCOMES FROM MAMMOGRAPHY IN NORTH CAROLINAU01CA070040 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YANKASKAS, BONNIE C · 1995 to 2011
$6.4M
San Francisco Mammography Registry-A Research SourceU01CA063740 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KERLIKOWSKE, KARLA M · 1994 to 2011
$6.2M
STRATEGIC STUDIES IN BREAST CANCER SURVEILLANCEU01CA086082 · NCI · DARTMOUTH COLLEGE · PI ONEGA, TRACY · 2000 to 2011
$4.9M
REFERRAL PATTERNS AND COST ANALYSIS OF SCREENING MAMMOGRAPHY--FOLLOW-UP/BIOPSYU01CA063736 · NCI · COOPER INSTITUTE · PI CUTTER, GARY · 1994 to 2004
$2.7M
NEW MEXICO MAMMOGRAPHY PROJECTU01CA069976 · NCI · UNIVERSITY OF NEW MEXICO · PI ROSENBERG, ROBERT D · 1995 to 2005
$2.7M
OUTCOMES ACROSS THE SPECTRUM OF BREAST CANCER CAREU01CA088283 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2000 to 2010
$2.6M
Cancer Control at the Intersection of Aging ResearchK05CA096940 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2002 to 2011
$1.5M
NCI NIH HHS K05 CA096940NCI NIH HHS KO5CA96940NCI NIH HHS P01 CA154292NCI NIH HHS P01CA154292NCI NIH HHS U01 CA088283NCI NIH HHS U01CA088283NCI NIH HHS U01 CA152958NCI NIH HHS U01CA152958NCI NIH HHS U01CA63731NCI NIH HHS U01CA63736NCI NIH HHS U01CA63740NCI NIH HHS U01CA69976NCI NIH HHS U01CA70013NCI NIH HHS U01CA70040NCI NIH HHS U01CA86076NCI NIH HHS U01CA86082PHS HHS 261201100031C
6 · The paper itself

Abstract

backgroundUS breast cancer mortality is declining, but thousands of women still die each year.

methodsTwo established simulation models examine 6 strategies that include increased screening and/or treatment or elimination of obesity versus continuation of current patterns. The models use common national data on incidence and obesity prevalence, competing causes of death, mammography characteristics, treatment effects, and survival/cure. Parameters are modified based on obesity (defined as BMI  ≥  30 kg/m(2) ). Outcomes are presented for the year 2025 among women aged 25+ and include numbers of cases, deaths, mammograms and false-positives; age-adjusted incidence and mortality; breast cancer mortality reduction and deaths averted; and probability of dying of breast cancer.

resultsIf current patterns continue, the models project that there would be about 50,100-57,400 (range across models) annual breast cancer deaths in 2025. If 90% of women were screened annually from ages 40 to 54 and biennially from ages 55 to 99 (or death), then 5100-6100 fewer deaths would occur versus current patterns, but incidence, mammograms, and false-positives would increase. If all women received the indicated systemic treatment (with no screening change), then 11,400-14,500 more deaths would be averted versus current patterns, but increased toxicity could occur. If 100% received screening plus indicated therapy, there would be 18,100-20,400 fewer deaths. Eliminating obesity yields 3300-5700 fewer breast cancer deaths versus continuation of current obesity levels.

conclusionsMaximal reductions in breast cancer deaths could be achieved through optimizing treatment use, followed by increasing screening use and obesity prevention.

Indexed as

Models, StatisticalAdultAgedBreast NeoplasmsFalse Positive ReactionsFemaleHumansIncidenceMammographyMass ScreeningMiddle AgedObesitySurvival AnalysisUnited Statesbreast cancermammographymodelingobesitysimulationtreatment

Identifiers

PMID23625540
PMCPMC3700651
OpenAlexW2024184875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.